戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  Ser or Thr and at the carbohydrate sites of alpha 1-acid glycoprotein.
2 ich correlated with plasma concentrations of alpha-1 acid glycoprotein.
3 high binding affinity of UCN-01 to the human alpha-1-acid glycoprotein.
4 alin-like prostaglandin D synthase (L-PGDS), alpha(1) -acid glycoprotein (AAG), transferrin (TF), cer
5 omplexity in the carbohydrate composition of alpha(1)-acid glycoprotein (AAG) makes it an ideal model
6       A new method for the immobilization of alpha(1)-acid glycoprotein (AGP) in high-performance liq
7                                 At baseline, alpha(1)-acid glycoprotein (AGP) was elevated in 42.9% a
8 ned by radioimmunoassays, and transthyretin, alpha(1)-acid glycoprotein (AGP), alpha(1)-antichymotryp
9 roteins (APPs), C-reactive protein (CRP) and alpha(1)-acid glycoprotein (AGP), individually and in co
10   We examined the associations between serum alpha(1)-acid glycoprotein (AGP), serum C-reactive prote
11 by binding to the acute phase serum protein, alpha(1)-acid glycoprotein (AGP).
12  primarily responsible for drug binding, the alpha(1)-acid-glycoprotein (AGP) and human serum albumin
13 ed at a micro liquid-liquid interface, using alpha(1)-acid-glycoprotein (AGP) as a chiral acute phase
14 ere was a positive correlation between serum alpha-1 acid glycoprotein (AGP) concentration and plasma
15 tive protein (CRP) concentrations >5 mg/L or alpha-1-acid glycoprotein (AGP) concentrations >1 g/L, 2
16 tive protein (CRP) concentrations >5 mg/L or alpha-1-acid glycoprotein (AGP) concentrations >1 g/L, 2
17 tive protein (CRP) concentrations >5 mg/L or alpha-1-acid glycoprotein (AGP) concentrations >1 g/L; 3
18 and detecting purified as well as endogenous alpha-1-acid glycoprotein (AGP) in human plasma.
19 biomarkers such as C-reactive protein (CRP), alpha-1-acid glycoprotein (AGP), ferritin, and retinol.
20                   Plasma C-reactive protein, alpha(1)-acid glycoprotein, alpha(1)-antitrypsin, haptog
21 red the relation between C-reactive protein, alpha 1 acid glycoprotein and albumin, an acute phase pr
22                There was no relation between alpha 1 acid glycoprotein and either myocardial infarcti
23                                        Human alpha-1 acid glycoprotein and a therapeutic monoclonal a
24 garded as being random, we have found, using alpha-1-acid glycoprotein and antitrypsin as model syste
25 ntly labeled proteins, ubiquitin, myoglobin, alpha-1-acid glycoprotein and lysozyme, were incubated w
26         Ribonuclease B, bovine fetuin, human alpha 1-acid glycoprotein, and the diamine oxidase (from
27  hydratase, glutathione-s-transferase omega, alpha-1-acid-glycoprotein, and phosphatidylethanolamine-
28 t alpha 1-acid glycoprotein, fetuin or human alpha 1-acid glycoprotein as acceptors together with the
29 enzyme measurement, alpha1-microglobulin and alpha(1)-acid glycoprotein by immunonephelometry, and se
30 (C-reactive protein concentration >5 mg/L or alpha-1-acid glycoprotein concentration >1 g/L), 2) the
31 fused with protein A, was incubated with rat alpha 1-acid glycoprotein, fetuin or human alpha 1-acid
32 ctivity with N-acetylneuramin lactose, human alpha-1-acid glycoprotein, fetuin, colominic acid, and b
33  human IgG (for core fucosylation) and human alpha-1-acid-glycoprotein (for antenna fucosylation).
34 ns, full length heparins, and N-glycans from alpha-1-acid glycoproteins from four mammalian species.
35                               Alterations in alpha 1-acid glycoprotein gene expression correlated in
36 easured by C-reactive protein (> 5 mg/L) and alpha(1)-acid glycoprotein (> 1 g/L) before applying cut
37 ter adjusting for conventional risk factors: alpha-1-acid glycoprotein (hazard ratio [HR] 1.67 per 1-
38 lls at 25.0-50.0 nM, even in the presence of alpha(1) acid glycoprotein, human serum albumin, normal
39 ycoproteins included ribonuclease B, fetuin, alpha(1)-acid glycoprotein, immunoglobulin, and thyroglo
40 ity failed to transfer sialic acid to asialo alpha(1)-acid glycoprotein, indicating that this enzyme
41 n increase in steady-state concentrations of alpha 1-acid glycoprotein messenger RNA that peaked at 1
42                                          The alpha 1-acid glycoprotein messenger RNA was not detected
43 etinol)] and >/=1 biomarker of inflammation (alpha-1-acid glycoprotein or C-reactive protein).
44 ethylpyrocarbonate (DEPC) was used to modify alpha 1-acid glycoprotein (orosomucoid, OMD) under vario
45 elevated C-reactive protein (P = 0.0029) and alpha-1-acid glycoprotein (P = 0.0023) at baseline.
46 more, they found that C-reactive protein and alpha-1-acid glycoprotein provide important and differen
47                       Carbohydrate chains on alpha 1-acid glycoprotein were converted to carry alpha-
48 in-1beta, interleukin-6, corticosterone, and alpha-1 acid glycoprotein were determined in serum, and
49 the levels of cytokines, corticosterone, and alpha-1 acid glycoprotein were significantly higher in t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。